230 related articles for article (PubMed ID: 27142025)
21. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs.
Kool M; Geurtsvankessel C; Muskens F; Madeira FB; van Nimwegen M; Kuipers H; Thielemans K; Hoogsteden HC; Hammad H; Lambrecht BN
J Leukoc Biol; 2011 Dec; 90(6):1177-90. PubMed ID: 21934071
[TBL] [Abstract][Full Text] [Related]
22. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.
Yamazaki S; Dudziak D; Heidkamp GF; Fiorese C; Bonito AJ; Inaba K; Nussenzweig MC; Steinman RM
J Immunol; 2008 Nov; 181(10):6923-33. PubMed ID: 18981112
[TBL] [Abstract][Full Text] [Related]
23. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
24. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
Tsuji T; Matsuzaki J; Kelly MP; Ramakrishna V; Vitale L; He LZ; Keler T; Odunsi K; Old LJ; Ritter G; Gnjatic S
J Immunol; 2011 Jan; 186(2):1218-27. PubMed ID: 21149605
[TBL] [Abstract][Full Text] [Related]
25. The role of the e3 ligase cbl-B in murine dendritic cells.
Wallner S; Lutz-Nicoladoni C; Tripp CH; Gastl G; Baier G; Penninger JM; Stoitzner P; Wolf D
PLoS One; 2013; 8(6):e65178. PubMed ID: 23762309
[TBL] [Abstract][Full Text] [Related]
26. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.
Jung S; Unutmaz D; Wong P; Sano G; De los Santos K; Sparwasser T; Wu S; Vuthoori S; Ko K; Zavala F; Pamer EG; Littman DR; Lang RA
Immunity; 2002 Aug; 17(2):211-20. PubMed ID: 12196292
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo assessment of in vivo DC-targeted antibodies in pre-clinical models.
Huang Q; Anandasabapathy N
Methods Enzymol; 2020; 632():417-430. PubMed ID: 32000908
[TBL] [Abstract][Full Text] [Related]
28. Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver.
Volckmar J; Gereke M; Ebensen T; Riese P; Philipsen L; Lienenklaus S; Wohlleber D; Klopfleisch R; Stegemann-Koniszewski S; Müller AJ; Gruber AD; Knolle P; Guzman CA; Bruder D
Sci Rep; 2017 Mar; 7():43985. PubMed ID: 28266658
[TBL] [Abstract][Full Text] [Related]
29. Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.
Petersen TR; Sika-Paotonu D; Knight DA; Simkins HM; Hermans IF
PLoS One; 2011 Mar; 6(3):e17657. PubMed ID: 21483862
[TBL] [Abstract][Full Text] [Related]
30. CD103
Lu L; Tanaka Y; Ishii N; Sasano T; Sugawara S
Eur J Immunol; 2017 Feb; 47(2):305-313. PubMed ID: 27861804
[TBL] [Abstract][Full Text] [Related]
31. Inducible targeting of cDCs and their subsets in vivo.
Loschko J; Rieke GJ; Schreiber HA; Meredith MM; Yao KH; Guermonprez P; Nussenzweig MC
J Immunol Methods; 2016 Jul; 434():32-8. PubMed ID: 27073171
[TBL] [Abstract][Full Text] [Related]
32. Altered lymph node composition in diphtheria toxin receptor-based mouse models to ablate dendritic cells.
van Blijswijk J; Schraml BU; Rogers NC; Whitney PG; Zelenay S; Acton SE; Reis e Sousa C
J Immunol; 2015 Jan; 194(1):307-15. PubMed ID: 25411201
[TBL] [Abstract][Full Text] [Related]
33. Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming.
Osmond TL; Farrand KJ; Painter GF; Ruedl C; Petersen TR; Hermans IF
J Immunol; 2015 Aug; 195(3):821-31. PubMed ID: 26078270
[TBL] [Abstract][Full Text] [Related]
34. Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation.
Butler M; Morel AS; Jordan WJ; Eren E; Hue S; Shrimpton RE; Ritter MA
Immunology; 2007 Mar; 120(3):362-71. PubMed ID: 17163964
[TBL] [Abstract][Full Text] [Related]
35. Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.
Nierkens S; den Brok MH; Garcia Z; Togher S; Wagenaars J; Wassink M; Boon L; Ruers TJ; Figdor CG; Schoenberger SP; Adema GJ; Janssen EM
Cancer Res; 2011 Oct; 71(20):6428-37. PubMed ID: 21788345
[TBL] [Abstract][Full Text] [Related]
36. CD205 (DEC-205): a recognition receptor for apoptotic and necrotic self.
Shrimpton RE; Butler M; Morel AS; Eren E; Hue SS; Ritter MA
Mol Immunol; 2009 Mar; 46(6):1229-39. PubMed ID: 19135256
[TBL] [Abstract][Full Text] [Related]
37. A novel CD4-CD8alpha+CD205+CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis.
Ruiz S; Beauvillain C; Mévélec MN; Roingeard P; Breton P; Bout D; Dimier-Poisson I
Cell Microbiol; 2005 Nov; 7(11):1659-71. PubMed ID: 16207252
[TBL] [Abstract][Full Text] [Related]
38. Sustained in vivo depletion of splenic langerin(+) CD8α(+) dendritic cells is well-tolerated by lang-DTREGFP mice.
Prendergast KA; Osmond TL; Ochiai S; Hermans IF; Kirman JR
J Immunol Methods; 2014 Apr; 406():104-9. PubMed ID: 24556588
[TBL] [Abstract][Full Text] [Related]
39. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node.
Kitano M; Yamazaki C; Takumi A; Ikeno T; Hemmi H; Takahashi N; Shimizu K; Fraser SE; Hoshino K; Kaisho T; Okada T
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1044-9. PubMed ID: 26755602
[TBL] [Abstract][Full Text] [Related]
40. The role of skin-derived dendritic cells in CD8+ T cell priming following immunization with lentivectors.
Furmanov K; Elnekave M; Lehmann D; Clausen BE; Kotton DN; Hovav AH
J Immunol; 2010 May; 184(9):4889-97. PubMed ID: 20357252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
